NCT03777072

Brief Summary

The study evaluates a novel web-based application for monitoring the postoperative pain in patients undergoing total ankle replacement, from preoperative condition to 30 days follow-up. The indexes provided by the app in terms of percentages of pain areas are compared with that obtained with traditional visual analogue scale. Moreover, the relation between the percentage of pain area and the presence of side effects of the intervention are compared as well.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2018

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 12, 2018

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

December 13, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 17, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2020

Completed
Last Updated

December 17, 2018

Status Verified

December 1, 2018

Enrollment Period

2.1 years

First QC Date

December 13, 2018

Last Update Submit

December 13, 2018

Conditions

Keywords

Total Ankle ReplacementPain Measurement

Outcome Measures

Primary Outcomes (3)

  • Pain area index

    Quantifies the percentage of pain area with respect to the total body area in the considered plane

    Through study completion, an average of 18 months

  • VAS score

    Continuous value ranging from 0 (minimum) to 10 (maximum), indicating the pain level reported by patient.

    Through study completion, an average of 18 months

  • Presence of side effects

    Dichotomic variable. Equal to 1 in case of reported side effects, 0 otherwise.

    Through study completion, an average of 18 months

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Subjects undergoing first implant of total ankle replacement

You may qualify if:

  • age from 18 to 60 years
  • ankle arthrosis grade 3 or 4, according to Kellgren-Lawrence classification
  • subject undergoing first implant of total ankle replacement
  • skeletal maturity
  • signed informed consent

You may not qualify if:

  • previous ankle replacement implants or ipsilateral ankle arthrodesis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Irccs Istituto Ortopedico Galeazzi

Milan, Milano, 20156, Italy

RECRUITING

Related Publications (6)

  • Boudreau SA, Badsberg S, Christensen SW, Egsgaard LL. Digital Pain Drawings: Assessing Touch-Screen Technology and 3D Body Schemas. Clin J Pain. 2016 Feb;32(2):139-45. doi: 10.1097/AJP.0000000000000230.

    PMID: 25756558BACKGROUND
  • Campbell WI, Lewis S. Visual analogue measurement of pain. Ulster Med J. 1990 Oct;59(2):149-54.

    PMID: 2278111BACKGROUND
  • Haeseler G, Schaefers D, Prison N, Ahrens J, Liu X, Karch A. Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone. BMC Anesthesiol. 2017 Jul 11;17(1):91. doi: 10.1186/s12871-017-0383-6.

    PMID: 28693439BACKGROUND
  • Hartrick C, Van Hove I, Stegmann JU, Oh C, Upmalis D. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study. Clin Ther. 2009 Feb;31(2):260-71. doi: 10.1016/j.clinthera.2009.02.009.

    PMID: 19302899BACKGROUND
  • Matthews M, Rathleff MS, Vicenzino B, Boudreau SA. Capturing patient-reported area of knee pain: a concurrent validity study using digital technology in patients with patellofemoral pain. PeerJ. 2018 Mar 8;6:e4406. doi: 10.7717/peerj.4406. eCollection 2018.

    PMID: 29568700BACKGROUND
  • Nett MP. Postoperative pain management. Orthopedics. 2010 Sep;33(9 Suppl):23-6. doi: 10.3928/01477447-20100722-60.

    PMID: 20839719BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Federico Federico, MD

    IRCCS Istituto Ortopedico Galeazzi

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 13, 2018

First Posted

December 17, 2018

Study Start

December 12, 2018

Primary Completion

December 30, 2020

Study Completion

December 30, 2020

Last Updated

December 17, 2018

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will not share

Locations